# Achieve Life Sciences Inc. (QUIT)

Source: https://www.quantisnow.com/company/QUIT
Generated: 2026-11-21T08:25:41.968Z

- Ticker: QUIT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SEC CIK: 0000949858
- Website: https://www.achievelifesciences.com

## About

AchieveRx, The Quit Company (Nasdaq: ACHV; QUIT effective November 10, 2026 ; formerly doing business as Achieve Life Sciences, Inc. ) is a late-stage pharmaceutical company with a singular focus on nicotine dependence. AchieveRx's mission is to develop medicine for people who want to quit smoking or vaping. That medicine is cytisinicline, an investigational compound. Three ideas guide the Company: simplicity, science, and second chances, for good.

## Latest QUIT news and filings

- 2026-11-16 21:20 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Achieve Life Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-achieve-life-sciences-6794341)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/QUIT
- Earnings history: https://www.quantisnow.com/earnings/QUIT
- Dividend history: https://www.quantisnow.com/dividends/QUIT
- Insider transactions: https://www.quantisnow.com/insiders/QUIT
- Options chain: https://www.quantisnow.com/options/QUIT
- SEC 8-K filings only: https://www.quantisnow.com/company/QUIT/8-k
- RSS and alerts for QUIT: https://www.quantisnow.com/docs/rss-feeds.md
